在不同心力衰竭模型中探索分子的潜力:一篇评论
Daria Kornieieva1,2, Barbora Kalocayova1,3, Jan Slezak1
1Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
International journal of molecular sciences
|December 11, 2025
概括
分子 (H2) 通过减少氧化应激和炎症来治疗心力衰竭 (HF) 是有前途的. 需要进一步的研究来证实它在各种高频类型中的有效性.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 生物医学科学 生物医学科学
背景情况:
- 全球心力衰竭 (HF) 患病率正在上升,导致严重的发病率和死亡率.
- 风涉及复杂的心脏重塑,增高和收缩能力受损,死亡率高.
- 目前的HF治疗方法不足以解决所有潜在的病理机制.
研究的目的:
- 审查目前关于分子 (H2) 在心力衰竭中的心脏保护作用的文献.
- 总结H2减轻HF病理的潜在机制.
- 突出需要进一步研究H2在各种HF模型中的有效性.
主要方法:
- 对分子 (H2) 和心力衰竭 (HF) 模型的现有研究进行系统审查.
- 在HF中分析H2对氧化应激,炎症,亡和心脏重塑的影响.
- 评估H2对线粒体功能和细胞代谢的影响在HF的背景下.
主要成果:
- 分子 (H2) 显示出对心脏健康有益的抗氧化,抗炎和抗丧性质.
- 在HF中,H2可以有效调节心脏氧化应激,炎症,心肌细胞死亡和线粒体功能障碍.
- 有证据表明,H2可以减轻心脏重塑,包括高和纤维化,在实验性HF模型中.
结论:
- 分子 (H2) 通过向关键的病理途径,为心力衰竭 (HF) 提供了潜在的治疗策略.
- 2调节氧化应激,炎症和心脏重塑的能力需要进一步研究.
- 对不同类型心力衰竭的H2治疗的临床可行性和效率需要广泛的未来研究.
相关概念视频
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668
Heart Failure I: Introduction
660
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
660
Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Heart Failure III: Clinical Manifestations
440
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
440


